Solubiomix develops and distributes specialty generic pharmaceuticals to independent and specialty pharmacies.

Supported the CEO and responsible for developing short and long-term growth strategies, identifying and addressing development issues, and evaluating internal operating procedures within the organization.Responsible for developing a commercial plan and cash flow analysis to launch a prescription product for Sulfagenix's lead compound in parallel with drug development plans. Led disease state prioritization project for the companies lead compound and IP rights. Led and organized grant submissions for Sulfagenix including a NIH R01, NIH R29, and US Army grant submission. Helped develop and facilitate a scientific advisory board and clinical advisory board for product development and commercialization.

Responsible for leading corporate strategy development and execution, including support to biomarker and therapeutic area strategy, pipeline development, route to market strategies, pricing strategies, pre-commercialization, clinical study protocol support, and external partnerships.Co-led due diligence efforts along with the President that resulted in an acquisition of Pamlab Inc. by Nestle Health Science April 1st 2013. Led and developed strategy to produce company vision, strategic intent, corporate objectives and balanced score card which helped support the achievement of corporate objectives. Initiated and helped execute an novel routes to market which helped exceed revenue/profitability objectives through a 25% growth rate in 2012. Further helped position the company in Personalized Medicine through the development through biomarker evidence, marketing research, and revising the company brand including a revised logo/tag line. Led and supported pre-commercialization drug development including a detailed drug valuation, IP strategy, diagnostic partner development, protocol development, and support to FDA regulatory strategy through Phase II development. Led the therapeutic prioritization strategy, new indications, and pre-commercialization launch plan for pipeline development

Responsible for marketing promoted and non-promoted products including P&L responsibilities, brand strategies, KOL development, business development opportunities, people development, and pipeline support.Held P&L responsibilities and managed a multi-million dollar budget that helped meet or exceed sales and profit targets for the company each year. Responsible for brand positioning, message elements and promotional tactic of promoted products for consistent execution across each communication vehicle: sales force, web, speakers, advertising, and publications. Helped produce more peer reviewed publications and KOL programs specific to Pamlab products than at any time in company history. Developed a comprehensive 1-5 year strategy and forecast for four promoted product s and pipeline development

Led the pre-commercial development and commercial launch of a novel therapeutic option for depression. Responsible for all aspects of a successful product launch including, development and execution of a marketing plan, launch tactics, forecasting, coordination with manufacturing, market access, and hiring/developing a small specialty sales force

Responsible for developing and growing a medical device franchise with surgeons and gastroenterology specialist.

Responsible for leading growth initiatives in various roles that included specialty sales management, global marketing, and marketing research.